What InterVest Co. does

InterVest Co., Ltd. (인터베스트) is a South Korean venture capital firm founded in 1999 that specializes in early-stage and growth-stage investments across ICT and biotech/healthcare sectors. The firm manages 18 active funds with combined assets under management (AUM) exceeding $1.7 billion USD and has invested over $1.4 billion USD across 450+ portfolio companies since inception. InterVest employs 33+ investment professionals structured across multiple Investment Divisions, a Risk Management function, and a Planning & Strategy group, and operates across Korea, Southeast Asia (Singapore, Vietnam, Indonesia, Malaysia, India), and the United States. The firm is registered under South Korea's Venture Investment Promotion Act and is headquartered in the Trade Tower, Gangnam-gu, Seoul. It ranks in the top 2% of operational performance among Korean venture capital firms.

The firm's investment thesis is technology-oriented, prioritizing ventures with core technical barriers, global competitiveness, and standalone scalability over short-term metrics. Sector coverage in ICT spans artificial intelligence, fintech, metaverse, energy/ESG, semiconductor, platform, mobility, smart society, space tech, DeFi/CeFi, and NFT/X2E; biotech coverage includes novel modalities, big data & AI-driven biotechnology, and genome-based precision medicine. Notable portfolio companies include Rebellions (AI semiconductors), Riiid (AI education), Galux (AI protein therapeutics), WIRobotics (humanoid robotics), Vitestro (autonomous robotic phlebotomy), and Link Alpha (financial investment AI). Recent active deals in early 2026 — co-leading Galux's $29M Series B, participating in WIRobotics' ~$63.5M Series B and Vitestro's $70M Series B, and backing Link Alpha's seed — demonstrate continued deployment velocity. InterVest does not build proprietary technology products; its external presence is a corporate website (intervest.co.kr) showcasing portfolio and investment activities.

InterVest generates revenue through traditional venture capital economics: management fees (typically 1–2% annually on assets under management) on its 18 funds, and carried interest (typically 20% of profits above hurdle rates) on successful exits. Capital is sourced from institutional limited partners including Korean policy banks (e.g., IBK, KIF) and other institutional investors, structured as successive limited partnership fund vehicles. Fund vintage sizes have grown materially over time — from KRW 80 billion at inception in 1999 to KRW 3,122 billion for the 2023 Deeptech Investment Fund and KRW 3,000 billion for the 2024 IBK Innovation-InterVest Deep Tech Fund II — with thematic vehicles covering Web3 (2022), deeptech (2023, 2024), NextG communications (2023), and Malaysia expansion (2024). The firm does not publicly disclose revenue or financial performance metrics.

Name

InterVest Co.

Legal name

InterVest Co., Ltd. (인터베스트)

Website

https://intervest.co.kr

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

InterVest Co. is a South Korean venture capital firm founded in 1999, managing 18 funds with over $1.7 billion in AUM. It invests in early-stage ICT and biotech startups across Korea, Southeast Asia, and the United States, with 450+ portfolio companies.

Ownership category

akta.pro rank

Product category

Venture Capital Investment Management

NAICS

Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (52394)

SIC

Investment Advice (6282)

akta.pro primary industry

Co-Investment Syndication & Allocation Intermediation (FSAEALAH)

Keywords

• Venture capital investing
• Startup funding
• ICT investments
• Biotech venture capital
• Early-stage investments

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Investment Management: InterVest generates revenue through management fees charged on funds under management (typically 1-2% annually) and carried interest (typically 20% of profits above a hurdle rate). The firm has raised 18 funds with combined assets under management exceeding $1.7 billion USD.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

InterVest Co. is a venture capital firm that invests capital in early-stage and growth-stage startups across ICT and biotech/healthcare sectors. The firm manages 18 funds with combined assets under management exceeding $1.7 billion USD, having invested in over 450 companies since its founding in 1999. It generates revenue through management fees on funds under management and carried interest on investment returns.

Product overview

InterVest is a venture capital firm that provides investment services to startups, not a product company. They do not offer a unified product platform or modules. Their services include identifying and investing in promising ventures, providing follow-on investment support, assisting with overseas market expansion, and facilitating partnerships with large corporations. The company operates across two primary sectors: ICT (artificial intelligence, fintech, metaverse, energy/ESG, semiconductor, platform, mobility, smart society, space tech, DeFi/CeFi, NFT) and BIO (biotech/healthcare including novel modalities, big data & AI-driven biotechnology, and genome-based precision medicine). InterVest invests in startups across Korea, Southeast Asia, and the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investment Funds
• Startup Investment and Follow-On Capital
• Portfolio Company Support Services

Quantifiable outcome

• Top 2% operational performance ranking
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• NH Investment & Securities (Venture Arm): NH Investment & Securities operates a venture and growth capital platform investing in Korean startups. It participated alongside InterVest in WIRobotics' Series B, making it a direct competitor in Korean growth-stage technology investing.
• Hana Ventures: Hana Ventures is the venture arm of Hana Financial Group, investing in Korean startups across fintech, mobility, and deeptech. It co-invested with InterVest in WIRobotics, representing a direct peer with comparable fund sizes and similar Korean institutional backing.
• SoftBank Ventures Asia (SBVA): SBVA is the rebranded SoftBank Ventures Asia, a major Korean-anchored VC investing across AI, fintech, and enterprise. It participated alongside InterVest in WIRobotics' Series B and competes in the same Korean growth-stage tech market.
• Mirae Asset Capital: Mirae Asset Capital is the venture and growth capital arm of Mirae Asset Group, with Korean tech and biotech investments. It participated in Galux's Series B alongside InterVest, making it a direct peer in Korean tech and bio venture capital.
• Smilegate Investment: Smilegate Investment is a major Korean VC with funds spanning gaming, deeptech, and SE Asia. It co-invested with InterVest in WIRobotics and Link Alpha, and is a direct peer in Korean early-growth and Series B investing.
• Kakao Ventures: Kakao Ventures is the corporate venture arm of Kakao, focused on early-stage Korean startups in AI, fintech, blockchain, and content. It is a frequent co-investor alongside InterVest (e.g., Link Alpha seed round) and competes for the same Korean tech startup pipeline.
• Atinum Investment: Atinum Investment is a leading Korean venture capital and growth equity firm with multiple sector-focused funds across ICT and bio/healthcare. It directly competes with InterVest for Korean Series B deals (e.g., co-invested with InterVest in Galux's Series B) and shares a similar LP base and institutional structure.
• Company K Partners: Company K Partners is a Korean venture capital firm with funds in deeptech, ICT, and bio. It co-invested with InterVest in WIRobotics' Series B and is a direct competitor in Korean growth-stage tech investing.
• DAYLI Partners: DAYLI Partners is a Korean VC investing in early-stage tech and biotech startups. It co-led Galux's Series B with InterVest and shares similar sector focus and Korean institutional LP backing.

Broad incumbents

• KB Investment: KB Investment is the venture and growth capital arm of KB Financial Group, one of Korea's largest financial groups. As a broad incumbent with deep pockets and parent-group backing, it competes with InterVest for large Korean Series B and growth-stage deals while offering a wider product suite including buyouts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments143 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InterVest Co.